Bio-India Pharma Private Limited, a active private limited company, was established on 14 June 2000 in Mumbai, Maharashtra, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U15100MH2000PTC127200. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.25 Cr and a paid-up capital of ₹6.70 M.
It upholds a compliant status. Employing 64 professional, Its leadership includes Prabhakar Kukyan Vithal (Director), Savio Remedious Dcosta (Whole-Time Director). Past directors included Suryaprakash Vithal Kukyan, Sudhakar Kuckian. It holds ₹4.65 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 39 2018 Shivamgandhi Nagar Bandra (East), Mumbai, Maharashtra, 400051.
U15100MH2000PTC127200
127200
14 June 2000
₹1.25 Cr
₹6.70 M
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Bio-India Pharma Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Prabhakar Kukyan Vithal | Director | 14 Jun 2000 | Current |
| Savio Remedious Dcosta | Whole-Time Director | 14 Jun 2000 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 01 Oct 2007 | Past |
| Pramod Abcsdd | Director | 07 May 2013 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Bio-India Pharma Private Limited, for the financial year ended 2023, experienced modest growth in revenue, with a 4.57% increase. The company also saw a substantial fall in profitability, with a 73.35% decrease in profit. The company's net worth dipped by a decrease of 1.85%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Bio-India Pharma's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹46,529,450.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 04 Jun 2021 | Canara Bank | ₹9.33 M | Open |
| 14 Oct 2020 | Sidbi | ₹5.00 M | Open |
| 23 Jun 2020 | Canara Bank | ₹0.13 M | Open |
| 17 Jun 2020 | Canara Bank | ₹1.88 M | Open |
| 17 Nov 2017 | Canara Bank | ₹1.80 Cr | Open |
Explore comprehensive loan charge details -
Bio-India Pharma has a workforce of 64 employees as of Apr 09, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Bio-India Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bio-India Pharma's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity A charge with Canara Bank of Rs. 1.80 Cr registered on 17 Nov 2017 with Charge ID 100157237 was modified on 19 Apr 2025. was completed.
Progress on Bio-India Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was documented.
Bio-India Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was recorded as a recent event.
Progress on A charge with Canara Bank of Rs. 0.93 Cr registered on 04 Jun 2021 with Charge ID 100455821 was modified on 21 Dec 2021. was documented.
A charge with Canara Bank amounted to Rs. 0.93 Cr with Charge ID 100455821 was registered on 04 Jun 2021. was recorded as a recent event.
A charge with Sidbi amounted to Rs. 0.50 Cr with Charge ID 100381416 was registered on 14 Oct 2020. was recorded as a recent event.
The CIN of Bio-India Pharma Private Limited is U15100MH2000PTC127200.
Bio-India Pharma Private Limited is headquartered at 39 2018 Shivamgandhi Nagar Bandra (East), Mumbai, Maharashtra, 400051.
Bio-India Pharma Private Limited was incorporated on 14 June 2000.
The current directors of Bio-India Pharma Private Limited are
The primary industry of Bio-India Pharma Private Limited is Manufacturing.
Bio-India Pharma Private Limited is unlisted.
The authorized capital of Bio-India Pharma Private Limited is ₹1.25 Cr, and the paid-up capital is ₹6.70 M.
The compliance status of Bio-India Pharma Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX